Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oncotelic Therapeutics, Inc. | Director | Stock Options | 451K | Jul 8, 2021 | Direct | ||
RenovoRx, Inc. | Director | Stock Options (right to buy) | 25.1K | Oct 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNXT | RenovoRx, Inc. | Oct 1, 2023 | 1 | $0 | 4 | Oct 2, 2023 | Director |
RNXT | RenovoRx, Inc. | Oct 1, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
RNXT | RenovoRx, Inc. | Mar 10, 2022 | 2 | $0 | 4 | Mar 14, 2022 | Director |
RNXT | RenovoRx, Inc. | Oct 1, 2021 | 2 | $0 | 4 | Oct 5, 2021 | Director |
RNXT | RenovoRx, Inc. | Aug 25, 2021 | 0 | $0 | 3 | Aug 25, 2021 | Director |
OTLC | Oncotelic Therapeutics, Inc. | Jul 8, 2021 | 1 | $0 | 4 | Jul 16, 2021 | Director |